TWiV 853: COVID-19 clinical update #97 with Dr. Daniel Griffin

January 15, 2022

In COVID-19 clinical update #97, Daniel Griffin covers immunity after infection recognized by CDC, outcomes before and after Omicron, infectious viral load in Delta vs Omicron, PCR vs rapid antigen tests, booster interval shortened to 5 months, risk factors for severe outcomes in vaccinated, cross-reactive memory T cells, vaccine effectiveness vs MIS-C, and Rivaroxiban for thromboprophylaxis.

Click arrow to play
Download TWiV 853 (58 MB .mp3, 48 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 853: COVID-19 clinical update #97 with Dr. Daniel Griffin

  1. John Porter Jan 15, 2022

    Hey Vincent, Can I get those parasites without boarders internship details mentioned by Dr. Griffin? I’d like to pass it along to a friend.

    • profvrr Jan 15, 2022

      I’ve added the pdf for the Internship in the show notes.

  2. Jeanine Jan 18, 2022

    Any studies those unvaccinated and staying home without ever infected?